What combination of antibiotics is commonly used to treat bacterial meningitis?

Prepare for your Microbial Growth Phases, Oxygen Needs, and Immunity Types Test. Use our multiple-choice questions and detailed explanations for each answer to enhance your understanding and ensure success!

Multiple Choice

What combination of antibiotics is commonly used to treat bacterial meningitis?

Explanation:
Bacterial meningitis requires antibiotics that reach the central nervous system and cover the common pathogens, including Streptococcus pneumoniae, Neisseria meningitidis, and, in older or immunocompromised patients, Listeria. A third-generation cephalosporin like ceftriaxone or cefotaxime provides strong, broad coverage for these organisms and penetrates the CSF well when meninges are inflamed. Vancomycin is added to guard against penicillin- and cephalosporin-resistant pneumococci, ensuring protection against resistant strains. Together, this pairing offers broad empiric coverage while the exact cause is identified. The other options don’t provide the same reliable CNS-penetrant, broad-spectrum coverage: macrolides and tetracyclines have limited CNS penetration and aren’t first-line for meningitis; aminoglycosides alone cross poorly into the CSF and are not effective as monotherapy for meningitis; fluoroquinolones aren’t standard empiric therapy due to variable CNS penetration and resistance concerns.

Bacterial meningitis requires antibiotics that reach the central nervous system and cover the common pathogens, including Streptococcus pneumoniae, Neisseria meningitidis, and, in older or immunocompromised patients, Listeria. A third-generation cephalosporin like ceftriaxone or cefotaxime provides strong, broad coverage for these organisms and penetrates the CSF well when meninges are inflamed. Vancomycin is added to guard against penicillin- and cephalosporin-resistant pneumococci, ensuring protection against resistant strains. Together, this pairing offers broad empiric coverage while the exact cause is identified. The other options don’t provide the same reliable CNS-penetrant, broad-spectrum coverage: macrolides and tetracyclines have limited CNS penetration and aren’t first-line for meningitis; aminoglycosides alone cross poorly into the CSF and are not effective as monotherapy for meningitis; fluoroquinolones aren’t standard empiric therapy due to variable CNS penetration and resistance concerns.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy